Last reviewed · How we verify
NCT05280743: PRECISE-CD
Precision Opioid Care After Cesarean Delivery (PRECISE-CD)
trial testing Oxycodone in Cesarean Section Complications in 341 participants. Completed in 1 June 2024.
24 September 2023
Quick facts
| Lead sponsor | Grace Lim, MD, MS |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 341 |
| Start date | 28 March 2022 |
| Primary completion | 24 September 2023 |
| Estimated completion | 1 June 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Oxycodone (oxycodone) — full drug profile →
Conditions studied
- Cesarean Section Complications — all drugs for Cesarean Section Complications →
- Opioid Use — all drugs for Opioid Use →
Sponsor
Grace Lim, MD, MS — full company profile →
Who can join
18 and older, female only, with Cesarean Section Complications or Opioid Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to study serious clinical problems from surgical pain and the use of oxycodone or other opioids in women having a Cesarean Delivery to improve the safety and efficacy of surgical pain relief. This research will ultimately improve the safety and efficacy of surgical pain relief with opioids by preoperative risk predictions and personalized care with the right dose of the right analgesic for each patient.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05280743
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Oxycodone
Trials testing the same drug.
- NCT07153003 — Efficacy And Safety Of Tramadol And Oxycodone Versus Oxycodone Monotherapy For Pain Control After Primary Total Knee And · Phase 4 · enrolling by invitation
- NCT06757140 — Opioid Drug Interaction Study · Phase 1, PHASE2 · recruiting
- NCT05965492 — Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery · Phase 3 · withdrawn
- NCT06517069 — Effect of TEAS Combined With Oxycodone on Postoperative Visceral Pain in Gynecologic Laparoscopic Patients · NA · recruiting
- NCT06340932 — Impact of Opioid Avoidance Protocol for ACL Reconstruction · completed
Other recruiting trials for Cesarean Section Complications
Currently open trials in the same condition.
- NCT07278037 — Trends in the Administration of Tranexamic Acid for Postpartum Hemorrhage · recruiting
- NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
- NCT07130747 — Effect of Myofascial Release Versus Deep Friction Massage on Abdominal Recovery and Scar After Cesarean Section · NA · recruiting
- NCT05791630 — The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) · NA · recruiting
- NCT07049705 — Factors Influencing Bradycardia During Spinal Anesthesia in Obstetric Patients Undergoing Cesarean Section · active not recruiting
Other Grace Lim, MD, MS trials
Trials by the same sponsor.
- NCT05906368 — Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypotension · NA · completed
- NCT05907213 — Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1) · Phase 1 · completed
- NCT05487196 — Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia · Phase 2 · completed
- NCT04925765 — Virtual Reality Biofeedback for Postpartum Anxiety and Depression · NA · completed
- NCT04365465 — BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05280743 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Grace Lim, MD, MS
- Last refreshed: 5 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05280743.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing